BAOZUN INC-SPN ADR (BZUN)

US06684L1035 - ADR

2.6413  -0.13 (-4.65%)

Fundamental Rating

3

Taking everything into account, BZUN scores 3 out of 10 in our fundamental rating. BZUN was compared to 32 industry peers in the Broadline Retail industry. BZUN has a bad profitability rating. Also its financial health evaluation is rather negative. BZUN is not valued too expensively and it also shows a decent growth rate.



2

1. Profitability

1.1 Basic Checks

BZUN had negative earnings in the past year.
In multiple years BZUN reported negative net income over the last 5 years.
In multiple years BZUN reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -2.66%, BZUN is doing worse than 68.75% of the companies in the same industry.
BZUN has a Return On Equity (-6.79%) which is in line with its industry peers.
Industry RankSector Rank
ROA -2.66%
ROE -6.79%
ROIC N/A
ROA(3y)-3.63%
ROA(5y)-0.57%
ROE(3y)-9.09%
ROE(5y)-1.87%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 72.66%, BZUN belongs to the best of the industry, outperforming 96.88% of the companies in the same industry.
BZUN's Gross Margin has improved in the last couple of years.
BZUN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.19%
GM growth 5Y3.13%

3

2. Health

2.1 Basic Checks

BZUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BZUN has been increased compared to 1 year ago.
The number of shares outstanding for BZUN has been increased compared to 5 years ago.
BZUN has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.24, we must say that BZUN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BZUN (1.24) is worse than 68.75% of its industry peers.
BZUN has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
BZUN's Debt to Equity ratio of 0.40 is in line compared to the rest of the industry. BZUN outperforms 40.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 1.24
ROIC/WACCN/A
WACC5.73%

2.3 Liquidity

A Current Ratio of 1.94 indicates that BZUN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.94, BZUN is in the better half of the industry, outperforming 65.63% of the companies in the same industry.
A Quick Ratio of 1.66 indicates that BZUN should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.66, BZUN is doing good in the industry, outperforming 68.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.66

4

3. Growth

3.1 Past

The earnings per share for BZUN have decreased strongly by -232.62% in the last year.
Looking at the last year, BZUN shows a small growth in Revenue. The Revenue has grown by 4.90% in the last year.
BZUN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.32% yearly.
EPS 1Y (TTM)-232.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.48%
Revenue 1Y (TTM)4.9%
Revenue growth 3Y-0.15%
Revenue growth 5Y10.32%
Sales Q2Q%16.4%

3.2 Future

The Earnings Per Share is expected to grow by 76.92% on average over the next years. This is a very strong growth
BZUN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.13% yearly.
EPS Next Y127.49%
EPS Next 2Y111.22%
EPS Next 3Y81.26%
EPS Next 5Y76.92%
Revenue Next Year4.88%
Revenue Next 2Y5.01%
Revenue Next 3Y4.64%
Revenue Next 5Y5.13%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

BZUN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 7.14, the valuation of BZUN can be described as very cheap.
87.50% of the companies in the same industry are more expensive than BZUN, based on the Price/Forward Earnings ratio.
BZUN is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.16, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 7.14

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

BZUN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BZUN's earnings are expected to grow with 81.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y111.22%
EPS Next 3Y81.26%

0

5. Dividend

5.1 Amount

No dividends for BZUN!.
Industry RankSector Rank
Dividend Yield N/A

BAOZUN INC-SPN ADR

NASDAQ:BZUN (12/3/2024, 12:22:49 PM)

2.6413

-0.13 (-4.65%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap157.14M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.14
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.66%
ROE -6.79%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 72.66%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.94
Quick Ratio 1.66
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-232.62%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y127.49%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4.9%
Revenue growth 3Y-0.15%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y